{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:39:09Z","timestamp":1780486749457,"version":"3.54.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00309","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T12:37:02Z","timestamp":1564144622000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure"],"prefix":"10.3389","volume":"7","author":[{"given":"Silvia","family":"Corti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina I.","family":"Mazzocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Mand\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna F.","family":"Moscatiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Cheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Baldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Clementi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00228-006-0177-0","article-title":"Prevalence and patterns of antidepressant drug use during pregnancy","volume":"62","author":"Ververs","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00787-014-0558-3","article-title":"Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review","volume":"23","author":"El Marroun","year":"2014","journal-title":"Eur Child Adolesc Psychiatry."},{"key":"B3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1192\/bjp.bp.113.127746","article-title":"Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children","volume":"205","author":"El Marroun","year":"2014","journal-title":"Br J Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/archgenpsychiatry.2010.111","article-title":"A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction","volume":"67","author":"Grote","year":"2010","journal-title":"Arch Gen Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bpobgyn.2013.08.017","article-title":"Maternal depression, anxiety and stress during pregnancy and child outcome; what needs to be done","volume":"28","author":"Glover","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-clinpsy-032813-153626","article-title":"Antidepressant use in pregnant and postpartum women","volume":"10","author":"Yonkers","year":"2014","journal-title":"Annu Rev Clin Psychol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1176\/appi.ajp.2015.14080989","article-title":"The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month","volume":"173","author":"Salisbury","year":"2016","journal-title":"Am J Psychiatry."},{"key":"B8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3109\/14767058.2013.845157","article-title":"Depression during pregnancy: a risk factor for adverse neonatal outcomes?","volume":"27","author":"Szegda","year":"2014","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bpobgyn.2015.04.004","article-title":"Depression during pregnancy","volume":"29","author":"Pearlstein","year":"2015","journal-title":"Best Pract Res Clin Obstetr Gynaecol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00737-011-0246-y","article-title":"SUICIDALITY in the perinatal period: comparison of two self-report instruments","volume":"15","author":"Mauri","year":"2012","journal-title":"Arch Womens Ment Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00737-007-0192-x","article-title":"Suicidal ideation in pregnancy: assessment and clinical implications","volume":"10","author":"Newport","year":"2007","journal-title":"Arch Womens Ment Health."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/AOG.0b013e31816fd910","article-title":"ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007)","volume":"111","year":"2008","journal-title":"Obstet Gynecol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/JCP.0000000000000087","article-title":"Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring","volume":"34","author":"Deligiannidis","year":"2014","journal-title":"J Clin Psychopharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0181082","DOI":"10.1371\/journal.pone.0181082","article-title":"Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: changes in drug disposition","volume":"12","author":"Westin","year":"2017","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"994","DOI":"10.4088\/JCP.10m06461","article-title":"Mother-infant antidepressant concentrations, maternal depression, and perinatal events","volume":"72","author":"Sit","year":"2011","journal-title":"J Clin Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/FTD.0000000000000370","article-title":"Pharmacokinetics and pharmacogenetics of selective serotonin reuptake inhibitors during pregnancy: an observational study","volume":"39","author":"Pogliani","year":"2017","journal-title":"Ther Drug Monit"},{"key":"B19","first-page":"528","article-title":"Development of a LC-MS\/MS method for therapeutic drug monitoring of antidepressants and antipsychotics in human plasma","volume":"33","author":"Baldelli","year":"2011","journal-title":"Ther Drug Monit"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.4088\/JCP.12r07966","article-title":"Antidepressant exposure during pregnancy and congenital malformations: is there an association?","volume":"74","author":"Grigoriadis","year":"2013","journal-title":"J Clin Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.4088\/JCP.12r07967","article-title":"The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis","volume":"74","author":"Grigoriadis","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.4088\/JCP.12r07968","article-title":"The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis","volume":"74","author":"Grigoriadis","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1111\/1471-0528.12821","article-title":"Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway","volume":"121","author":"Skurtveit","year":"2014","journal-title":"BJOG"},{"key":"B24","first-page":"304","article-title":"Smoking and depression: a review","volume":"41","author":"Mendelsohn","year":"2012","journal-title":"Austr Fam Phys"},{"key":"B25","unstructured":"LondonRCOGPrevention and Management of Postpartum Haemorrhage (Green-top No. 52).2016"},{"key":"B26","first-page":"25","article-title":"Risk of spontaneous preterm birth in relation to maternal depressive, anxiety and stress symptoms","volume":"58","author":"Sanchez","year":"2013","journal-title":"J Reprod Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.genhosppsych.2013.08.002","article-title":"A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight","volume":"36","author":"Huang","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects","volume":"370","author":"Huybrechts","year":"2014","journal-title":"New Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e92778","DOI":"10.1371\/journal.pone.0092778","article-title":"Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis","volume":"9","author":"Huybrechts","year":"2014","journal-title":"PLoS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/ije\/dyv351","article-title":"Selective serotonin re-uptake inhibitor use during pregnancy: association with offspring birth size and gestational age","volume":"45","author":"Viktorin","year":"2016","journal-title":"Int J Epidemiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/pubmed\/fdw050","article-title":"Impact of maternal and paternal smoking on birth outcomes","volume":"39","author":"Inoue","year":"2017","journal-title":"J Public Health."},{"key":"B32","first-page":"525","article-title":"Association between maternal smoking and low birth weight in Switzerland: the EDEN study","volume":"135","author":"Chiolero","year":"2005","journal-title":"Swiss Med Wkly."},{"key":"B33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S1701-2163(16)34157-3","article-title":"Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin\/norepinephrine reuptake inhibitors","volume":"31","author":"Koren","year":"2009","journal-title":"J Obstet Gynaecol Can."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","article-title":"Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications","volume":"293","author":"Moses-Kolko","year":"2005","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.23970\/AHRQEPCERTA216","author":"McDonagh","year":"2014","journal-title":"Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1176\/appi.ajp.2015.14121575","article-title":"Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from population-based national register data","volume":"172","author":"Malm","year":"2015","journal-title":"Am J Psychiatry."},{"key":"B37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/acps.12042","article-title":"Antidepressant use in pregnancy: a critical review focused on risks and controversies","volume":"127","author":"Byatt","year":"2013","journal-title":"Acta Psychiatr Scand."},{"key":"B38","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.ajog.2006.02.019","article-title":"Selective serotonin reuptake inhibitors and adverse pregnancy outcomes","volume":"194","author":"Wen","year":"2006","journal-title":"Am J ObstetGynecol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/sj.jp.7211352","article-title":"Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis","volume":"25","author":"Lattimore","year":"2005","journal-title":"J Perinatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/da.20883","article-title":"Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment","volume":"28","author":"Salisbury","year":"2011","journal-title":"Depress Anxiety."},{"key":"B41","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1001\/archpediatrics.2010.51","article-title":"Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age","volume":"164","author":"Oberlander","year":"2010","journal-title":"Arch Pediatr Adolesc Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00309\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T12:37:05Z","timestamp":1564144625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00309\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,26]]},"references-count":41,"alternative-id":["10.3389\/fped.2019.00309"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00309","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,26]]},"article-number":"309"}}